Remember, even a 5 to 10% weight loss could improve metabolic outcomes 24
The four-week investment in tolerability pays dividends for the remaining 40+ weeks of your protocol
Remaining readouts, TRIUMPH-3 and the other sub-trials, are anticipated through 2026 to mid-2027, while TRIUMPH-Outcomes (the cardiovascular outcomes trial) follows a longer timeline through 2028
In research and clinical studies, Retatrutide has shown: Dramatic weight loss effects (comparable or even superior to semaglutide and tirzepatide) Improved blood sugar control Enhanced insulin sensitivity Increased energy expenditure Fat loss with muscle preservation How It Works Retatrutides triple action targets multiple pathways: GLP-1 : Reduces appetite, delays gastric emptying, and improves insulin response
Semaglutide: How Next-Generation Weight Loss Medications Compare GLP-1 medications have changed the conversation around medical weight loss
Real Treatments with Real Results Lose weight up to 15-20% On average, people on semaglutide lose 15-20% of their weight in a year Book Now with our Registered Nurse Injectors Tab Content This is a basic text element
